Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (9): 1438-1442.doi: 10.16352/j.issn.1001-6325.2022.09.1438
• Mini Reviews • Previous Articles Next Articles
LI He-tong, REN Jing-jing, WANG Wen-hao, HAO Min*
Received:
2021-12-13
Revised:
2022-05-06
Online:
2022-09-05
Published:
2022-09-02
CLC Number:
LI He-tong, REN Jing-jing, WANG Wen-hao, HAO Min. Advances in the study of the role of estrogen and its receptor combined with HPV in cervical cancer microenvironment[J]. Basic & Clinical Medicine, 2022, 42(9): 1438-1442.
[1] | Okunade KS. Human papillomavirus and cervical cance[J]. J Obstet Gynaecol, 2020, 40: 602-608. |
[2] | Wang Z, Yang A, Yang J, et al. Dietary nutrient intake related to higher grade cervical intraepithelial neoplasia risk: a Chinese population-based study[J].Nutr Metab (Lond), 2020, 17: 100-114. |
[3] | Johansson ALV, Fredriksson I, Mellemkjaer L, et al. Cancer survival in women diagnosed with pregnancy-associated cancer: an overview using nationwide registry data in Sweden 1970-2018[J]. Eur J Cancer, 2021, 155: 106-115. |
[4] | Loopik DL, IntHout J, Melchers WJG, et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study[J]. Eur J Cancer, 2020,124: 102-109. |
[5] | Wang T, Jin J, Qian C, et al. Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment[J]. Cancer Cell Int, 2021, 21: 295-308. |
[6] | Ramachandran B. Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis[J]. Endocr Relat Cancer, 2017, 24: R99-R108. |
[7] | Bttinger P, Schreiber K, Hyjek E, et al. Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens[J]. Carcinogenesis, 2020, 41: 1605-1615. |
[8] | De Nola R, Menga A, Castegna A, et al. The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: biological pathways and therapeutic implication[J]. Int J Mol Sci, 2019,20:2401-2430. |
[9] | Chen Y, Gu Y, Gu Y, et al. Long noncoding RNA LINC00899/miR-944/ESR1 axis regulates cervical cancer cell proliferation, migration, and invasion[J]. J Interferon Cytokine Res, 2021, 41: 220-233. |
[10] | Gomez-Gomez Y, Organista-Nava J, Ocadiz-Delgado R, et al. The expression of miR-21 and miR-143 is deregu-lated by the HPV16 E7 oncoprotein and 17beta-estradiol[J]. Int J Oncol, 2016, 49: 549-558. |
[11] | Wang C, Zhang T, Wang K, et al. ER-alpha36 promotes the malignant progression of cervical cancer mediated by estrogen via HMGA2[J]. Frontiers in oncology, 2021,11:712849. doi: 10.3389/fonc.2021.712849. |
[12] | Zhang X, Zhang A, Zhang X, et al. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells[J]. Virus research, 2021, 306: 198602. doi: 10.3389/fonc.2021.712849. |
[13] | Fan Q, Huang T, Sun X, et al. miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor alpha and androgen receptor in cervical cancer[J]. Exp Ther Med, 2021, 21: 414-424. |
[14] | Riera Leal A, Ortiz-Lazareno PC, Jave-Suarez LF, et al. 17β-estradiol-induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress[J]. Int J Oncol, 2020, 56: 33-46. |
[15] | Bristol ML, James CD, Wang X, et al. Estrogen attenuates the growth of human papillomavirus-positive epithelial cells[J]. mSphere, 2020, 5:e00049-20. doi: 10.1128/mSphere.00049-20. |
[16] | Kumagai K, Takanashi M, Ohno SI, et al. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7[J]. Oncogene, 2021, 40: 3695-3706. |
[17] | Elson DA, Riley RR, Lacey A, et al. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis[J]. Cancer Res, 2000, 60: 1267-1275. |
[18] | Remoue F, Jacobs N, Miot V, et al. High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix[J]. Am J Obstet Gynecol, 2003,189: 1660-1665. |
[19] | Spurgeon ME, Uberoi A, McGregor SM, et al. A novel in vivo infection model to study papillomavirus-mediated disease of the female reproductive tract[J]. mBio, 2019, 10:e00180-19. doi: 10.1128/mBio.00180-19. |
[20] | De Nola R, Loizzi V, Cicinelli E, et al. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications[J]. Crit Rev Oncol Hematol, 2021,162: 103343. doi: 10.1016/j.critrevonc.2021.103343. |
[21] | Jayshree RS. The immune microenvironment in human papilloma virus-induced cervical lesions-evidence for estrogen as an immunomodulator[J]. Front Cell Infect Microbiol, 2021, 11: 649815. doi: 10.3389/fcimb.2021.649815. |
[22] | Ramachandran B, Murhekar K, Sundersingh S. SERMs suppresses the growth of ERα positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERalpha expression[J]. Am J Cancer Res, 2021, 11: 3335-3353. |
[23] | Kim L, Park SA, Park H, et al. Bazedoxifene, a GP130 Inhibitor, modulates EMT signaling and exhibits antitumor effects in HPV-positive cervical cancer[J]. Int J Mol Sci, 2021, 22:8693-8706. |
[24] | Chauhan N, Maher DM, Yallapu MM, et al. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth[J]. Sci Rep, 2019, 9:10917-10929. |
[25] | Kwon S, Ahn SH, Jeong WJ, et al. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma[J]. J Transl Med, 2020,18: 240-252. |
[1] | WANG Liang, XIA Longkuo, ZHANG Jianmin. Research progress of brain organoids in drug development [J]. Basic & Clinical Medicine, 2024, 44(9): 1208-1213. |
[2] | HAN Yingdong, WANG Song, ZHANG Yun, ZENG Xuejun. Analysis of clinical features of hypereosinophilic syndrome complicated with peripheral arterial embolism [J]. Basic & Clinical Medicine, 2024, 44(8): 1157-1161. |
[3] | GAO Yidan, JIANG Xuehan, ZHANG Hong, YANG Peiran. Development of novel therapies targeting at dysregulated signaling pathways in pulmonary arterial hypertension [J]. Basic & Clinical Medicine, 2024, 44(8): 1088-1093. |
[4] | ZHANG Wei, ZHANG Zhen, LIU Dong, JIANG Houzhou, LIANG Wei. Comparison of adverse reactions and effects of IMRT combined with different chemotherapy regimens in patients with early stage esophageal squamous cell carcinoma [J]. Basic & Clinical Medicine, 2024, 44(7): 1018-1022. |
[5] | DUAN Ran, LI Qingyuan, FENG Tong. Metabolic reprogramming in idiopathic pulmonary fibrosis [J]. Basic & Clinical Medicine, 2024, 44(6): 882-886. |
[6] | Growth and Development and Gonadal Diseases Committee of Chinese Aging Well Association. Consensus on endocrine management for children and adolescents with craniopharyngioma surgeries [J]. Basic & Clinical Medicine, 2024, 44(5): 585-598. |
[7] | FU Chen, LI Ping. Research progress in the treatment of severe aplastic anemia [J]. Basic & Clinical Medicine, 2024, 44(5): 719-723. |
[8] | LIU Zhen, WANG Dalian, ZHANG Jie, ZHANG Qixing, WANG Fei. Intensive phototherapy don't affect cellular immune function and short-term reactions after discharge in neonatal hyperbilirubinemia [J]. Basic & Clinical Medicine, 2024, 44(3): 379-383. |
[9] | Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping. Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer [J]. Basic & Clinical Medicine, 2024, 44(3): 303-307. |
[10] | LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai. Efficacy of cinobufacini capsule combined with docetaxel plus cisplatin chemotherapy for the treatment of non-small cell lung cancer [J]. Basic & Clinical Medicine, 2024, 44(2): 247-251. |
[11] | . Drug therapy for intracranial germ cell tumor [J]. Basic & Clinical Medicine, 2024, 44(10): 1350-1356. |
[12] | . Advances in pharmacotherapy for angiosarcoma [J]. Basic & Clinical Medicine, 2024, 44(10): 1363-1367. |
[13] | . Targeted therapy and immunotherapy for malignant mesothelioma [J]. Basic & Clinical Medicine, 2024, 44(10): 1342-1349. |
[14] | . Role of Ghrelin in gastric cancer [J]. Basic & Clinical Medicine, 2024, 44(10): 1460-1464. |
[15] | . Association of seven antibody levels in lung cancer with chemotherapy effect and prognosis in patients with NSCLC [J]. Basic & Clinical Medicine, 2024, 44(10): 1383-1387. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 183
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 266
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||